Gary S Mintz

Author PubWeight™ 327.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011 10.66
2 A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004 5.67
3 Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 2012 4.29
4 Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol 2004 3.67
5 Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006 3.45
6 In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol 2010 2.85
7 Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation 2003 2.72
8 Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 2011 2.46
9 Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005 2.42
10 Validation of intravascular ultrasound-derived parameters with fractional flow reserve for assessment of coronary stenosis severity. Circ Cardiovasc Interv 2011 2.35
11 Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol 2007 2.32
12 A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. JACC Cardiovasc Interv 2009 2.30
13 Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 2009 2.23
14 Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 2003 2.18
15 Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. JACC Cardiovasc Interv 2009 2.12
16 A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003 2.07
17 Differentiation of early from advanced coronary atherosclerotic lesions: systematic comparison of CT, intravascular US, and optical frequency domain imaging with histopathologic examination in ex vivo human hearts. Radiology 2012 2.06
18 Late target lesion revascularization after implantation of sirolimus-eluting stent. Catheter Cardiovasc Interv 2008 2.03
19 The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J Am Coll Cardiol 2010 1.90
20 Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol 2010 1.86
21 Incidence, morphology, angiographic findings, and outcomes of intramural hematomas after percutaneous coronary interventions: an intravascular ultrasound study. Circulation 2002 1.79
22 Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 2003 1.77
23 Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2005 1.73
24 Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis. J Am Coll Cardiol 2005 1.72
25 Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 2004 1.72
26 Preintervention angiographic and intravascular ultrasound predictors for side branch compromise after a single-stent crossover technique. Am J Cardiol 2011 1.67
27 Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration: HEAVEN study. Circ J 2011 1.65
28 In vivo virtual histology intravascular ultrasound correlates of risk factors for sudden coronary death in men: results from the prospective, multi-centre virtual histology intravascular ultrasound registry. Eur Heart J 2008 1.65
29 Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era. Am J Cardiol 2011 1.63
30 Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study. Circulation 2013 1.62
31 Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2003 1.62
32 Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease. Circ Cardiovasc Interv 2011 1.62
33 Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implications. Circulation 2002 1.61
34 Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation 2005 1.60
35 Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol 2002 1.59
36 Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 2005 1.59
37 Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis. JACC Cardiovasc Imaging 2009 1.58
38 Mechanical complications of everolimus-eluting stents associated with adverse events: an intravascular ultrasound study. EuroIntervention 2014 1.57
39 Short- and long-term results after multivessel stenting in diabetic patients. J Am Coll Cardiol 2004 1.57
40 Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 2005 1.57
41 Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC Cardiovasc Interv 2010 1.56
42 Impact of gender and age on in vivo virtual histology-intravascular ultrasound imaging plaque characterization (from the global Virtual Histology Intravascular Ultrasound [VH-IVUS] registry). Am J Cardiol 2009 1.56
43 Intravascular ultrasound assessment of spontaneous coronary artery dissection. Am J Cardiol 2002 1.55
44 Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. EuroIntervention 2009 1.53
45 Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 2006 1.51
46 Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions. Am J Cardiol 2009 1.49
47 Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. JACC Cardiovasc Imaging 2012 1.48
48 Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial. Circulation 2004 1.48
49 Randomised comparison of strut coverage between Nobori biolimus-eluting and sirolimus-eluting stents: an optical coherence tomography analysis. EuroIntervention 2014 1.47
50 Compensatory enlargement of the left main coronary artery: insights from the PROSPECT study. Coron Artery Dis 2014 1.47
51 Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II. Circulation 2005 1.46
52 Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 2003 1.45
53 Hemodynamic impact of changes in bifurcation geometry after single-stent cross-over technique assessed by intravascular ultrasound and fractional flow reserve. Catheter Cardiovasc Interv 2013 1.44
54 An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents. Am J Cardiol 2008 1.44
55 Dedicated calibration formulas permit correction of differences between measurements by different IVUS devices as demonstrated in atherosclerotic human coronary arteries in vitro. Int J Cardiovasc Imaging 2006 1.43
56 Virtual histology intravascular ultrasound evaluation of the left anterior descending coronary artery in patients with transient left ventricular ballooning syndrome. Kardiol Pol 2010 1.43
57 Pilot study with an intensified oral sirolimus regimen for the prevention of in-stent restenosis in de novo lesions: a serial intravascular ultrasound study. Catheter Cardiovasc Interv 2005 1.43
58 Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP Study). Circulation 2003 1.42
59 Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion. Catheter Cardiovasc Interv 2003 1.42
60 Intravascular ultrasound assessment of patterns of arterial remodeling in the absence of significant reference segment plaque burden in patients with coronary artery disease. J Am Coll Cardiol 2003 1.42
61 Intravascular ultrasound assessment of distal left main bifurcation disease: the importance of the polygon of confluence of the left main, left anterior descending, and left circumflex arteries. Catheter Cardiovasc Interv 2013 1.42
62 Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation 2004 1.42
63 Plaque shift and distal embolism in patients with acute myocardial infarction: a volumetric intravascular ultrasound analysis from the HORIZONS-AMI trial. Catheter Cardiovasc Interv 2013 1.41
64 Age-related effects of smoking on culprit lesion plaque vulnerability as assessed by grayscale and virtual histology-intravascular ultrasound. Coron Artery Dis 2015 1.40
65 Impact of the acute results on the long-term outcome after the treatment of in-stent restenosis: a serial intravascular ultrasound study. Catheter Cardiovasc Interv 2003 1.40
66 Serial intravascular ultrasound analysis of bifurcation lesions treated using the novel self-expanding sideguard side branch stent. Am J Cardiol 2009 1.40
67 Volumetric intravascular ultrasound assessment of mechanisms and results of stent expansion in heart transplant patients. Catheter Cardiovasc Interv 2012 1.39
68 Five-year outcomes of moderate or ambiguous left main coronary artery disease and the intravascular ultrasound predictors of events. J Invasive Cardiol 2008 1.39
69 Relation between baseline plaque burden and subsequent remodelling of atherosclerotic left main coronary arteries: a serial intravascular ultrasound study with long-term (> or =12 months) follow-up. Eur Heart J 2006 1.39
70 Novel method for extraction of a massive refractory coronary thrombus after stent implantation. Catheter Cardiovasc Interv 2005 1.39
71 Plaque composition and morphologic characteristics in significant left main bifurcation disease; virtual histology intravascular ultrasound study. Coron Artery Dis 2016 1.39
72 Morphological changes and clinical impact of unstable plaques within untreated segments of acute myocardial infarction patients during a 3-year follow-up: an analysis from the HORIZONS-AMI trial. Coron Artery Dis 2015 1.39
73 Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. Eur Heart J 2012 1.38
74 Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 2002 1.38
75 Benefits of cutting balloon before stenting. J Invasive Cardiol 2003 1.38
76 Impact of intracoronary injection of CD133+ bone marrow stem cells on coronary atherosclerotic progression in patients with STEMI: a COMPARE-AMI IVUS substudy. Coron Artery Dis 2016 1.38
77 Intravascular ultrasound comparison of the self-expanding Sideguard stent in the side branch versus a balloon-expandable stent in the main vessel to assess mechanisms of acute lumen gain in bifurcation lesions. Catheter Cardiovasc Interv 2013 1.37
78 Comparison of virtual histology to intravascular ultrasound of culprit coronary lesions in acute coronary syndrome and target coronary lesions in stable angina pectoris. Am J Cardiol 2007 1.35
79 Association of plaque characterization by intravascular ultrasound virtual histology and arterial remodeling. Am J Cardiol 2005 1.32
80 Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial. Circulation 2011 1.31
81 Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation 2005 1.30
82 In vivo characterization of coronary plaques: novel findings from comparing greyscale and virtual histology intravascular ultrasound and near-infrared spectroscopy. Eur Heart J 2011 1.24
83 Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes. JACC Cardiovasc Imaging 2012 1.24
84 Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. Am J Cardiol 2009 1.23
85 Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2013 1.21
86 Intravascular ultrasound classification of plaque distribution in left main coronary artery bifurcations: where is the plaque really located? Circ Cardiovasc Interv 2010 1.19
87 Assessing intermediate left main coronary lesions using intravascular ultrasound. Am Heart J 2007 1.18
88 Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. J Am Coll Cardiol 2006 1.17
89 Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes. Circulation 2003 1.16
90 Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. JACC Cardiovasc Imaging 2012 1.14
91 Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv 2002 1.12
92 Percutaneous recanalization of chronically occluded coronary arteries: procedural techniques, devices, and results. Catheter Cardiovasc Interv 2005 1.12
93 OCT analysis in patients with very late stent thrombosis. JACC Cardiovasc Imaging 2013 1.10
94 Definitions and methodology for the grayscale and radiofrequency intravascular ultrasound and coronary angiographic analyses. JACC Cardiovasc Imaging 2012 1.10
95 Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 2006 1.09
96 Intravascular ultrasound study of patterns of calcium in ruptured coronary plaques. Am J Cardiol 2005 1.09
97 Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes. JACC Cardiovasc Imaging 2012 1.08
98 Visual-functional mismatch between coronary angiography and fractional flow reserve. JACC Cardiovasc Interv 2012 1.08
99 The late stent malapposition develops also after paclitaxel balloon predilatation before bare-metal stent implantation: case description. Eur Heart J 2011 1.07
100 Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery. Am J Cardiol 2008 1.07
101 Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 2004 1.05
102 Relationship between palpography and virtual histology in patients with acute coronary syndromes. JACC Cardiovasc Imaging 2012 1.04
103 Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy. Circ Cardiovasc Interv 2011 1.04
104 Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study. J Am Coll Cardiol 2006 1.03
105 Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression. JACC Cardiovasc Imaging 2012 1.02
106 The site of plaque rupture in native coronary arteries: a three-vessel intravascular ultrasound analysis. J Am Coll Cardiol 2005 1.01
107 Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention. JACC Cardiovasc Imaging 2012 1.01
108 Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction. Circulation 2003 1.01
109 Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 2004 1.01
110 Prevalence, distribution, predictors, and outcomes of patients with calcified nodules in native coronary arteries: a 3-vessel intravascular ultrasound analysis from Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT). Circulation 2012 1.00
111 Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents. Circ Cardiovasc Interv 2013 1.00
112 Characteristics and clinical significance of angiographically mild lesions in acute coronary syndromes. JACC Cardiovasc Imaging 2012 0.99
113 A three-vessel virtual histology intravascular ultrasound analysis of frequency and distribution of thin-cap fibroatheromas in patients with acute coronary syndrome or stable angina pectoris. Am J Cardiol 2007 0.98
114 Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. JACC Cardiovasc Interv 2011 0.98
115 Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome. Am J Cardiol 2007 0.97
116 Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis. Circ Cardiovasc Interv 2011 0.97
117 OCT versus IVUS: accuracy versus clinical utility. JACC Cardiovasc Imaging 2013 0.97
118 Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries. Circulation 2004 0.96
119 Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. Circulation 2010 0.96
120 Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol 2004 0.95
121 Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). Am J Cardiol 2013 0.95
122 Incidence, location, magnitude, and clinical correlates of saphenous vein graft calcification: an intravascular ultrasound and angiographic study. Circulation 2005 0.95
123 Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 2004 0.95
124 Background incidence of late malapposition after bare-metal stent implantation. Circulation 2002 0.94
125 Procedural implications of intravascular ultrasound morphologic features of chronic total coronary occlusions. Am J Cardiol 2006 0.94
126 Optical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosis. EuroIntervention 2013 0.93
127 Between-centre reproducibility of volumetric intravascular ultrasound radiofrequency-based analyses in mild-to-moderate coronary atherosclerosis: an international multicentre study. EuroIntervention 2010 0.93
128 Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). J Am Coll Cardiol 2013 0.93
129 Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound. Circulation 2003 0.92
130 Intravascular ultrasound assessment of drug-eluting stent expansion. Am Heart J 2007 0.92
131 Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update. Eur J Echocardiogr 2011 0.92
132 Trends in the outcomes of percutaneous coronary intervention with the routine incorporation of fractional flow reserve in real practice. Eur Heart J 2013 0.92
133 Intravascular ultrasound versus optical coherence tomography guidance. J Am Coll Cardiol 2013 0.92
134 Comparison of intravascular ultrasound and angiographic assessment of coronary reference segment size in patients with type 2 diabetes mellitus. Am J Cardiol 2008 0.92
135 Randomized comparison of clinical outcomes between intravascular ultrasound and angiography-guided drug-eluting stent implantation for long coronary artery stenoses. JACC Cardiovasc Interv 2013 0.91
136 In vivo intravascular ultrasonic assessment of anomalous right coronary artery arising from left coronary sinus. Am J Cardiol 2009 0.91
137 Negative remodeling and calcified plaque in octogenarians with acute myocardial infarction: an intravascular ultrasound analysis. J Am Coll Cardiol 2006 0.91
138 Intravascular ultrasound assessment of drug-eluting stent coverage of the coronary ostium and effect on outcomes. Am J Cardiol 2013 0.91
139 Relation of stent design and stent surface material to subsequent in-stent intimal hyperplasia in coronary arteries determined by intravascular ultrasound. Am J Cardiol 2002 0.91
140 Comparison of usefulness of percutaneous coronary intervention guided by angiography plus computed tomography versus angiography alone using intravascular ultrasound end points. Am J Cardiol 2011 0.90
141 Clinical, angiographic, and intravascular ultrasound characteristics of early saphenous vein graft failure. J Am Coll Cardiol 2004 0.90
142 Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. Am J Cardiol 2010 0.90
143 Impact of myocardial bridge on clinical outcome after coronary stent placement. Am J Cardiol 2009 0.89
144 Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts. Am J Cardiol 2005 0.89
145 The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv 2011 0.89
146 Imaging of atherosclerotic plaque using radiofrequency ultrasound signal processing. J Nucl Cardiol 2006 0.89
147 Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis. Am J Cardiol 2010 0.88
148 Advances in intravascular imaging. Circ Cardiovasc Interv 2009 0.88
149 Attenuated plaque detected by intravascular ultrasound: clinical, angiographic, and morphologic features and post-percutaneous coronary intervention complications in patients with acute coronary syndromes. JACC Cardiovasc Interv 2009 0.88
150 Intravascular ultrasound profile analysis of ruptured coronary plaques. Am J Cardiol 2006 0.88
151 Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon. Am J Cardiol 2007 0.87
152 The importance of gender on coronary artery size: in-vivo assessment by intravascular ultrasound. Clin Cardiol 2004 0.87
153 Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries. J Am Coll Cardiol 2006 0.87
154 Intravascular ultrasound comparison of the retrograde versus antegrade approach to percutaneous intervention for chronic total coronary occlusions. JACC Cardiovasc Interv 2009 0.87
155 Volumetric intravascular ultrasound evidence that distal embolization during acute infarct intervention contributes to inadequate myocardial perfusion grade. Am J Cardiol 2003 0.86
156 Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus. Am J Cardiol 2008 0.86
157 Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation. J Am Coll Cardiol 2002 0.86
158 Drug-eluting stents in the real world: how intravascular ultrasound can improve clinical outcome. Am J Cardiol 2008 0.86
159 Remodeling index compared to actual vascular remodeling in atherosclerotic left main coronary arteries as assessed with long-term (> or =12 months) serial intravascular ultrasound. J Am Coll Cardiol 2006 0.86
160 Optical coherence tomography derived cut-off value of uncovered stent struts to predict adverse clinical outcomes after drug-eluting stent implantation. Int J Cardiovasc Imaging 2013 0.86
161 Serial gray scale intravascular ultrasound findings in late drug-eluting stent restenosis. Am J Cardiol 2012 0.86
162 Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation. JACC Cardiovasc Interv 2009 0.85
163 Intravascular ultrasound-derived predictors for fractional flow reserve in intermediate left main disease. JACC Cardiovasc Interv 2011 0.85
164 Virtual histology intravascular ultrasound analysis of non-culprit attenuated plaques detected by grayscale intravascular ultrasound in patients with acute coronary syndromes. Am J Cardiol 2009 0.85
165 Intravascular ultrasound and 3D angle measurements of coronary bifurcations. Catheter Cardiovasc Interv 2009 0.85
166 The axial distribution of lesion-site atherosclerotic plaque components: an in vivo volumetric intravascular ultrasound radio-frequency analysis of lumen stenosis, necrotic core and vessel remodeling. Ultrasound Med Biol 2008 0.85
167 Long-term follow-up of attenuated plaques in patients with acute myocardial infarction: an intravascular ultrasound substudy of the HORIZONS-AMI trial. Circ Cardiovasc Interv 2012 0.84
168 Serial intravascular ultrasound evidence of both plaque stabilization and lesion progression in patients with ruptured coronary plaques: effects of statin therapy on ruptured coronary plaque. Atherosclerosis 2006 0.84
169 Histopathologic validation of the intravascular ultrasound diagnosis of calcified coronary artery nodules. Am J Cardiol 2011 0.84
170 Angioscopic and virtual histology intravascular ultrasound characteristics of culprit lesion morphology underlying coronary artery thrombosis. Am J Cardiol 2011 0.84
171 Relation between angiographic lesion severity, vulnerable plaque morphology and future adverse cardiac events (from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study). Am J Cardiol 2012 0.84
172 Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial). Am J Cardiol 2005 0.84
173 Changes in left main bifurcation geometry after a single-stent crossover technique: an intravascular ultrasound study using direct imaging of both the left anterior descending and the left circumflex coronary arteries before and after intervention. Circ Cardiovasc Interv 2011 0.84
174 Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study. JACC Cardiovasc Imaging 2013 0.84
175 Late and very late drug-eluting stent malapposition: serial 2-year quantitative IVUS analysis. Circ Cardiovasc Interv 2010 0.84
176 Sex differences in the visual-functional mismatch between coronary angiography or intravascular ultrasound versus fractional flow reserve. JACC Cardiovasc Interv 2013 0.84
177 Impact of moderate lesion calcium on mechanisms of coronary stenting as assessed with three-dimensional intravascular ultrasound in vivo. Am J Cardiol 2003 0.84
178 IVUS-based FSI models for human coronary plaque progression study: components, correlation and predictive analysis. Ann Biomed Eng 2014 0.84
179 First report of a novel abluminal groove filled biodegradable polymer rapamycin-eluting stent in de novo coronary artery disease: results of the first in man FIREHAWK trial. Chin Med J (Engl) 2012 0.83
180 A virtual histology intravascular ultrasound analysis of coronary chronic total occlusions. Catheter Cardiovasc Interv 2012 0.83
181 Intravascular ultrasound evaluation of JETSTREAM atherectomy removal of superficial calcium in peripheral arteries. EuroIntervention 2015 0.83
182 The accuracy of length measurements using different intravascular ultrasound motorized transducer pullback systems. Int J Cardiovasc Imaging 2007 0.83
183 Intravascular ultrasound assessment of remodelling and reference segment plaque burden in type-2 diabetic patients. Eur Heart J 2007 0.83
184 Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions. Am J Cardiol 2004 0.83
185 High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study. JACC Cardiovasc Imaging 2012 0.83
186 Late incomplete apposition with excessive remodeling of the stented coronary artery following intravascular brachytherapy. Am J Cardiol 2003 0.83
187 Intravascular ultrasound assessment of cobalt chromium versus stainless steel drug-eluting stent expansion. Am J Cardiol 2010 0.83
188 Intravascular ultrasound assessment of angiographic filling defects in native coronary arteries: do they always contain thrombi? J Am Coll Cardiol 2004 0.83
189 Variability and accuracy of coronary CT angiography including use of iterative reconstruction algorithms for plaque burden assessment as compared with intravascular ultrasound-an ex vivo study. Eur Radiol 2012 0.82
190 Relation between individual plaque components and overall plaque burden in the prospective, multicenter virtual histology intravascular ultrasound registry. Am J Cardiol 2009 0.82
191 What to do about late incomplete stent apposition? Circulation 2007 0.82
192 Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials. Eur Heart J 2007 0.82
193 Effect of simvastatin on coronary lesion site remodeling: a serial intravascular ultrasound study. Cardiology 2006 0.82
194 Intravascular ultrasound predictors for edge restenosis after newer generation drug-eluting stent implantation. Am J Cardiol 2013 0.82
195 Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. Am J Cardiol 2006 0.82
196 Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy). Am J Cardiol 2011 0.82
197 Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or =80 years old versus those <80 years old. Am J Cardiol 2003 0.82
198 Optical coherence tomography in unprotected left main coronary artery stenting. EuroIntervention 2010 0.81
199 Intravascular ultrasound study of effects of overlapping sirolimus-eluting stents. Am J Cardiol 2004 0.81
200 Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy. Circulation 2009 0.81
201 Plaque composition by intravascular ultrasound and distal embolization after percutaneous coronary intervention. JACC Cardiovasc Imaging 2012 0.81
202 Impact of symptomatic peripheral arterial disease on 1-year mortality in patients undergoing percutaneous coronary interventions. J Endovasc Ther 2004 0.81
203 Human coronary plaque wall thickness correlated positively with flow shear stress and negatively with plaque wall stress: an IVUS-based fluid-structure interaction multi-patient study. Biomed Eng Online 2014 0.81
204 Effect of culprit-lesion remodeling versus plaque rupture on three-year outcome in patients with acute coronary syndrome. Am J Cardiol 2009 0.81
205 Dynamic nature of nonculprit coronary artery lesion morphology in STEMI: a serial IVUS analysis from the HORIZONS-AMI trial. JACC Cardiovasc Imaging 2013 0.81
206 Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III). Am J Cardiol 2003 0.81
207 Impact of renal function on coronary plaque morphology and morphometry in patients with chronic renal insufficiency as determined by intravascular ultrasound volumetric analysis. Am J Cardiol 2005 0.81
208 Relationship between coronary artery plaque composition by virtual histology intravascular ultrasound analysis and brachial-ankle pulse wave velocity in patients with coronary artery disease. Coron Artery Dis 2011 0.81
209 Repeated stenting of recurrent in-stent restenotic lesions: intravascular ultrasound analysis and clinical outcome. J Invasive Cardiol 2007 0.81
210 Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation. Am J Cardiol 2005 0.81
211 Plaque ruptures in stable angina pectoris compared with acute coronary syndrome. Int J Cardiol 2006 0.81
212 Vascular remodeling at both branch ostia in bifurcation disease assessed by intravascular ultrasound. Catheter Cardiovasc Interv 2013 0.81
213 Frequency and severity of plaque prolapse within Cypher and Taxus stents as determined by sequential intravascular ultrasound analysis. Am J Cardiol 2006 0.81
214 Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%. Am J Cardiol 2003 0.80
215 Serial intravascular ultrasound analysis of peri-stent remodeling and proximal and distal edge effects after sirolimus-eluting or paclitaxel-eluting stent implantation in patients with diabetes mellitus. Am J Cardiol 2009 0.80
216 Preintervention arterial remodeling affects vessel stretch and plaque extrusion during coronary stent deployment as demonstrated by three-dimensional intravascular ultrasound. Am J Cardiol 2003 0.80
217 Comparison of intravascular ultrasound, quantitative coronary angiography, and dual-source 64-slice computed tomography in the preprocedural assessment of significant saphenous vein graft lesions. Am J Cardiol 2011 0.80
218 Volumetric assessment of ulcerated ruptured coronary plaques with three-dimensional intravascular ultrasound in vivo. Am J Cardiol 2003 0.80
219 Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries. Am J Cardiol 2003 0.80
220 Impact of drug-eluting stents on distal vessels. Circ Cardiovasc Interv 2012 0.80
221 Atorvastatin accelerates both neointimal coverage and re-endothelialization after sirolimus-eluting stent implantation in a porcine model: new findings from optical coherence tomography and pathology. Circ J 2012 0.80
222 Impact of analyzing less image frames per segment for radiofrequency-based volumetric intravascular ultrasound measurements in mild-to-moderate coronary atherosclerosis. Int J Cardiovasc Imaging 2010 0.80
223 Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging. JACC Cardiovasc Imaging 2013 0.80
224 Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials. J Invasive Cardiol 2014 0.80
225 Impact of late drug-eluting stent malapposition on 3-year clinical events. J Am Coll Cardiol 2007 0.80
226 Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study. EuroIntervention 2012 0.80
227 Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study. EuroIntervention 2014 0.79
228 Dose heterogeneity may not affect the neointimal proliferation after gamma radiation for in-stent restenosis: a volumetric intravascular ultrasound dosimetric study. J Am Coll Cardiol 2002 0.79
229 Coronary artery calcification is inversely related to body morphology in patients with significant coronary artery disease: a three-dimensional intravascular ultrasound study. Eur Heart J Cardiovasc Imaging 2013 0.79
230 Optical coherence tomography assessment of a PLGA-polymer with electro-grafting base layer versus a PLA-polymer sirolimus-eluting stent at three-month follow-up: the BuMA-OCT randomised trial. EuroIntervention 2014 0.79
231 Usefulness of preprocedural coronary lesion morphology as assessed by intravascular ultrasound in predicting Thrombolysis In Myocardial Infarction frame count after percutaneous coronary intervention in patients with Q-wave acute myocardial infarction. Am J Cardiol 2003 0.79
232 Relation of intimal hyperplasia thickness to stent size in paclitaxel-coated stents. Am J Cardiol 2004 0.79
233 Intravascular ultrasound assessment of fibrous cap remnants after coronary plaque rupture. Am Heart J 2006 0.79
234 Relation of ruptured plaque culprit lesion phenotype and outcomes in patients with ST elevation acute myocardial infarction. Am J Cardiol 2011 0.79
235 Virtual histology intravascular ultrasound comparison of coronary chronic total occlusions versus non-occlusive lesions. Int J Cardiovasc Imaging 2013 0.79
236 Validation of minimal luminal area measured by intravascular ultrasound for assessment of functionally significant coronary stenosis comparison with myocardial perfusion imaging. JACC Cardiovasc Interv 2011 0.79
237 Effect of plaque volume on subsequent vessel remodeling at edges of sirolimus-eluting stents. Am J Cardiol 2006 0.79
238 Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial. Circulation 2004 0.79
239 The impact of cardiovascular risk factors on subclinical left main coronary artery disease: an intravascular ultrasound study. Am Heart J 2006 0.79
240 The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents. Am J Cardiol 2008 0.79
241 Effect of renal function on ultrasonic coronary plaque characteristics in patients with acute myocardial infarction. Am J Cardiol 2010 0.78
242 Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis. Am J Cardiol 2003 0.78
243 An intravascular ultrasound comparison of left anterior descending artery/first diagonal branch versus distal left main coronary artery bifurcation lesions. EuroIntervention 2013 0.78
244 Synergistic effect of cardiovascular risk factors on necrotic core in coronary arteries: a report from the global intravascular radiofrequency data analysis registry. JACC Cardiovasc Imaging 2009 0.78
245 Vascular remodeling and plaque composition between focal and diffuse coronary lesions assessed by intravascular ultrasound. Am J Cardiol 2004 0.78
246 Incidence and clinical correlates of ruptured plaques in saphenous vein grafts: an intravascular ultrasound study. J Am Coll Cardiol 2005 0.78
247 Dose volume histogram assessment of late stent malapposition after intravascular brachytherapy. Cardiovasc Radiat Med 2003 0.78
248 Minimally invasive coronary artery bypass grafting versus stenting for patients with proximal left anterior descending coronary artery disease. Am J Cardiol 2004 0.78
249 Comparison of manual thrombus aspiration with rheolytic thrombectomy in acute myocardial infarction. Circ Cardiovasc Interv 2013 0.78
250 In vivo intravascular ultrasound analysis of the absorption rate of the Angio-Seal vascular closure device in the porcine femoral artery. EuroIntervention 2010 0.78
251 Temporal course of neointimal hyperplasia following drug-eluting stent implantation: a serial follow-up optical coherence tomography analysis. Int J Cardiovasc Imaging 2014 0.78
252 An intravascular ultrasound analysis of the mechanisms of restenosis comparing drug-eluting stents with brachytherapy. Am J Cardiol 2006 0.78
253 A novel mechanism explaining early lumen loss following balloon angioplasty for the treatment of in-stent restenosis. Am J Cardiol 2005 0.78
254 Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound. Am Heart J 2010 0.78
255 The reality of vulnerable plaque detection. JACC Cardiovasc Imaging 2011 0.78
256 Intravascular-ultrasound-guided percutaneous transluminal coronary angioplasty/provisional stent implantation strategy: impact on long-term clinical follow-up. Int J Cardiovasc Intervent 2001 0.78
257 Relation between plaque progression and low-density lipoprotein cholesterol during aging as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound of the left main coronary artery. Am J Cardiol 2006 0.78
258 What have we learned about plaque rupture in acute coronary syndromes? Curr Cardiol Rep 2010 0.78
259 Comparative intravascular ultrasound analysis of ostial disease in the left main versus the right coronary artery. J Invasive Cardiol 2007 0.78
260 Prospective and systematic analysis of unexpected requests for non-cardiac surgery or other invasive procedures during the first year after drug-eluting stent implantation. Yonsei Med J 2014 0.78
261 Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI). Am J Cardiol 2007 0.78
262 Cardiovascular events in patients with coronary plaque rupture and nonsignificant stenosis. Am J Cardiol 2005 0.78
263 Level of Pregnancy-associated Plasma Protein-A Correlates With Coronary Thin-cap Fibroatheroma Burden in Patients With Coronary Artery Disease: Novel Findings From 3-Vessel Virtual Histology Intravascular Ultrasound Assessment. Medicine (Baltimore) 2016 0.78
264 Intravascular ultrasonic study of gender differences in ruptured coronary plaque morphology and its associated clinical presentation. Am J Cardiol 2007 0.78
265 Very late stent thrombosis with bare-metal stent: identifying severe stent malapposition and underexpansion by intravascular ultrasound. Einstein (Sao Paulo) 2013 0.78
266 Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis. Am J Cardiol 2006 0.78
267 Late intravascular ultrasound findings of patients treated with brachytherapy for diffuse in-stent restenosis. Catheter Cardiovasc Interv 2004 0.77
268 3D OCT versus FFR for jailed side-branch ostial stenoses. JACC Cardiovasc Imaging 2014 0.77
269 Intravascular ultrasound evidence of perivascular trauma during routine percutaneous coronary intervention. Int J Cardiovasc Imaging 2014 0.77
270 Comparison of ruptured plaques in native coronary arteries and in saphenous vein grafts: an intravascular ultrasound study. Am J Cardiol 2006 0.77
271 Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque. Am J Cardiol 2005 0.77
272 Letter by Stone and Mintz regarding article, "unreliable assessment of necrotic core by virtual histology intravascular ultrasound in porcine coronary artery disease". Circ Cardiovasc Imaging 2010 0.77
273 Frequency, mechanisms, and implications of late peri-stent contrast staining: analysis (from the HORIZONS-AMI Trial). Am J Cardiol 2013 0.77
274 An intravascular ultrasound appraisal of atherosclerotic plaque distribution in diseased coronary arteries. Am Heart J 2012 0.77
275 Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions. J Am Coll Cardiol 2003 0.77
276 Disease progression in nonintervened saphenous vein graft segments a serial intravascular ultrasound analysis. J Am Coll Cardiol 2009 0.77
277 Optical coherence tomographic evaluation of transplant coronary artery vasculopathy with correlation to cellular rejection. Circ Cardiovasc Interv 2014 0.77
278 The predictive value of computed tomography calcium scores: a comparison with quantitative volumetric intravascular ultrasound. Cardiovasc Revasc Med 2009 0.77
279 Intravascular ultrasound findings in patients with acute coronary syndromes with and without elevated troponin I level. Am J Cardiol 2002 0.77
280 Intravascular ultrasound comparison of left main coronary artery disease between white and Asian patients. Am J Cardiol 2013 0.77
281 Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis. Am J Cardiol 2005 0.77
282 Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass grafts. Am J Cardiol 2006 0.77
283 Incidence, predictors, and clinical impact of tissue prolapse after stent implantation for saphenous vein graft disease: intravascular ultrasound study. Int J Cardiol 2013 0.77
284 Treatment of diffuse in-stent restenosis with drug-eluting stents vs. intracoronary beta-radiation therapy: INDEED Study. Int J Cardiol 2008 0.76
285 Two-year safety and effectiveness of sirolimus-eluting stents (from a prospective registry). Am J Cardiol 2010 0.76
286 Relation of drug-eluting stent strut distribution to stent thrombosis in coronary arteries. Am J Cardiol 2009 0.76
287 Intravascular ultrasound assessment of ruptured atherosclerotic plaques in left main coronary arteries. Am J Cardiol 2005 0.76
288 Randomized comparison of carbon ion-implanted stent versus bare metal stent in coronary artery disease: the Asian Pacific Multicenter Arthos Stent Study (PASS) trial. Am Heart J 2005 0.76
289 Intravascular ultrasound assessment of the spatial distribution of ruptured coronary plaques in the left anterior descending coronary artery. Am Heart J 2006 0.76
290 Taxol-based eluting stents from theory to human validation: clinical and intravascular ultrasound observations. J Invasive Cardiol 2003 0.76
291 Angiographic and clinical outcomes of late total occlusion versus treatment failure without late total occlusion in patients after intracoronary radiation therapy for in-stent restenosis. Am J Cardiol 2004 0.76
292 Intravascular ultrasound observations of atherosclerotic lesion formation and restenosis in patients with diabetes mellitus. Int J Cardiovasc Intervent 1999 0.76
293 Radiofrequency-intravascular ultrasound assessment of lesion coverage after angiography-guided emergent percutaneous coronary intervention in patients with non-ST elevation myocardial infarction. Am J Cardiol 2013 0.76
294 Dominant contribution of negative remodeling to development of significant coronary bifurcation narrowing. Am J Cardiol 2003 0.76
295 Intravascular ultrasound findings that are predictive of no reflow after percutaneous coronary intervention for saphenous vein graft disease. Am J Cardiol 2012 0.76
296 Three-dimensional intravascular ultrasound evaluation of carina and plaque shift at the distal left main coronary artery bifurcation after treatment with a one-stent cross-over technique. Catheter Cardiovasc Interv 2013 0.76
297 Significance of prior percutaneous revascularisation in patients with acute coronary syndromes: insights from the prospective PROSPECT registry. EuroIntervention 2016 0.76
298 Impact of lesion location on intravascular ultrasound findings and short-term and five-year long-term clinical outcome after percutaneous coronary intervention for saphenous vein graft lesions. Int J Cardiol 2011 0.75
299 The Role of Virtual Histology Intravascular Ultrasound in the Identification of Coronary Artery Plaque Vulnerability in Acute Coronary Syndromes. Cardiol Rev 2016 0.75
300 Prevalence and anatomical features of acute longitudinal stent deformation: An intravascular ultrasound study. Catheter Cardiovasc Interv 2014 0.75
301 Cross-sectional and longitudinal positive remodeling after subintimal drug-eluting stent implantation: multiple late coronary aneurysms, stent fractures, and a newly formed stent gap between previously overlapped stents. JACC Cardiovasc Interv 2009 0.75
302 Unprotected left main intervention: the light at the end of the tunnel? Circ Cardiovasc Interv 2009 0.75
303 Multicenter assessment of the reproducibility of volumetric radiofrequency-based intravascular ultrasound measurements in coronary lesions that were consecutively stented. Int J Cardiovasc Imaging 2012 0.75
304 Impact of analyzing fewer image frames per segment during offline volumetric radiofrequency-based intravascular ultrasound measurements of target lesions prior to percutaneous coronary interventions. Int J Cardiovasc Imaging 2011 0.75
305 Volumetric intravascular ultrasound quantification of the amount of atherosclerosis and calcium in nonstenotic arterial segments. Am J Cardiol 2002 0.75
306 Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome. Am J Cardiol 2004 0.75
307 Diabetic coronary artery disease: how little we know and how little intravascular ultrasound has taught us. J Am Coll Cardiol 2008 0.75
308 Do we know what causes very late drug-eluting stent thrombosis? JACC Cardiovasc Interv 2012 0.75
309 Guiding coronary artery intervention: one technology to rule them all and in the darkness bind them. Can J Cardiol 2013 0.75
310 Reply: Can grayscale IVUS detect necrotic core-rich plaque? J Am Coll Cardiol 2014 0.75
311 Optimal stent expansion and complete neointimal coverage: does this association make sense? JACC Cardiovasc Interv 2009 0.75
312 Mechanism of luminal patency of the self-expanding Sideguard sidebranch stent: evaluation by intravascular ultrasound and optical coherence tomography. Catheter Cardiovasc Interv 2014 0.75
313 Implications of the presence and length of "geographic miss" on restenosis and the edge phenomenon in the INHIBIT trial. Am J Cardiol 2003 0.75
314 Analysis of stent edge restenosis with different forms of brachytherapy. Am J Cardiol 2002 0.75
315 Imaging and Physiology to Guide Venous Graft Interventions Without Contrast Administration in Advanced Renal Failure. J Invasive Cardiol 2017 0.75
316 Intravascular ultrasound findings in patients with restenosis of sirolimus- and paclitaxel-eluting stents. Int J Cardiol 2007 0.75
317 Progression of late stent malapposition beyond 2 years after sirolimus-eluting stent implantation. JACC Cardiovasc Interv 2009 0.75
318 Characteristics of Early Versus Late In-Stent Restenosis in Second- Generation Drug-Eluting Stents: An Optical Coherence Tomography Study. EuroIntervention 2017 0.75
319 Impact of plaque rupture and elevated C-reactive protein on clinical outcome in patients with acute myocardial infarction: an intravascular ultrasound study. J Invasive Cardiol 2008 0.75
320 Determinants of angiographically silent stenoses in patients with coronary artery disease. Am J Cardiol 2003 0.75
321 Guiding Light: Insights Into Atherectomy by Optical Coherence Tomography. JACC Cardiovasc Interv 2016 0.75
322 Intravascular ultrasound findings of stent fractures in patients with Sirolimus- and Paclitaxel-eluting stents. Am J Cardiol 2010 0.75
323 The clinical significance and management of patients with incomplete coronary angiography and the value of additional computed tomography coronary angiography. Int J Cardiovasc Imaging 2014 0.75
324 Images in cardiovascular medicine. Multiple ruptured plaques: serial intravascular ultrasound examinations. Circulation 2003 0.75
325 Impact of chronic statin therapy on clinical presentation and underlying lesion morphology in patients undergoing percutaneous intervention: an ADAPT-DES IVUS substudy. Coron Artery Dis 2017 0.75
326 Virtual histology-intravascular ultrasound assessment of lesion coverage after angiographically-guided stent implantation in patients with ST Elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2012 0.75
327 Intracoronary and noninvasive imaging for prediction of distal embolization and periprocedural myocardial infarction during native coronary artery percutaneous intervention. Circ Cardiovasc Imaging 2013 0.75
328 Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients >or=75 years of age versus those <75 years of age. Am J Cardiol 2003 0.75
329 Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis. Am J Cardiol 2003 0.75
330 Relation of plaque morphology to thrombolysis in myocardial infarction flow in acute myocardial infarction determined by intravascular ultrasound. Am J Cardiol 2003 0.75
331 Comparison of zotarolimus-eluting stents with sirolimus-eluting and paclitaxel-eluting stents: intimal hyperplasia and vascular changes assessed by volumetric intravascular ultrasound analysis. Circ Cardiovasc Interv 2011 0.75
332 Effect of Prior Aspirin Treatment on Patients With Acute Coronary Syndromes: Insights From the PROSPECT Study. J Invasive Cardiol 2015 0.75
333 Conversation in cardiology: should FFR and IVUS be counted as PCI? Catheter Cardiovasc Interv 2013 0.75
334 Late thrombosis after gamma-brachytherapy. Catheter Cardiovasc Interv 2003 0.75
335 Comparison of plaque morphology between peripheral and coronary artery disease (from the CLARITY and ADAPT-DES IVUS substudies). Coron Artery Dis 2017 0.75
336 In Vivo Validation of Mathematically-derived Fractional Flow Reserve for Assessing Hemodynamics of Coronary Tandem Lesions. EuroIntervention 2016 0.75
337 Spectrum of remodeling behavior observed with serial long-term (>/=12 months) follow-up intravascular ultrasound studies in left main coronary arteries. Am J Cardiol 2004 0.75
338 Lumen Measurements From Quantitative Coronary Angiography and IVUS: A PROSPECT Substudy. JACC Cardiovasc Imaging 2015 0.75
339 Favorable effect of gamma-radiation for in-stent restenosis: effect of diabetes on angiographic and clinical outcomes. Catheter Cardiovasc Interv 2004 0.75
340 Fusiform Appearance of Myocardial Bridging Detected by OCT. JACC Cardiovasc Imaging 2015 0.75
341 Is accurate intravascular ultrasound evaluation of the left circumflex ostium from a left anterior descending to left main pullback possible? Am J Cardiol 2010 0.75
342 Peri-stent reference segment plaque burden is associated with disease progression in saphenous vein grafts (a serial intravascular ultrasound assessment). Am J Cardiol 2007 0.75
343 Frequency and evolution of thin-capped fibroatheromas in left main coronary artery as assessed by serial virtual histology intravascular ultrasound analysis. J Invasive Cardiol 2014 0.75
344 Frequency and determinants of black holes in sirolimus-eluting stent restenosis. J Invasive Cardiol 2006 0.75
345 Feasibility and efficacy of tandem positioning on angiographic and clinical outcomes in the Intimal Hyperplasia Inhibition with Beta In-Stent Trial. Am J Cardiol 2003 0.75
346 Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials). Am J Cardiol 2008 0.75
347 Characteristics of high-risk atherosclerotic plaque using intravascular ultrasound-derived virtual histology. Expert Opin Med Diagn 2008 0.75
348 Differences in Underlying Culprit Lesion Morphology Between Men and Women: An IVUS Analysis From the ADAPT-DES Study. JACC Cardiovasc Imaging 2015 0.75
349 Relation between plaque composition and vascular remodeling in coronary lesions with different degrees of lumen narrowing as assessed with three-dimensional intravascular ultrasound in patients with stable angina pectoris. Am J Cardiol 2003 0.75
350 Late vascular response to repeat stenting for in-stent restenosis with and without radiation: an intravascular ultrasound volumetric analysis. Circulation 2002 0.75
351 Serial intravascular ultrasound comparison of the extent and distribution of intimal hyperplasia six months after stent implantation for de novo versus in-stent restenosis lesions. Am J Cardiol 2005 0.75
352 Impact of in-stent minimal lumen area at 9 months poststent implantation on 3-year target lesion revascularization-free survival: a serial intravascular ultrasound analysis from the TAXUS IV, V, and VI trials. Circ Cardiovasc Interv 2008 0.75
353 Worsening atrioventricular conduction after hospital discharge in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the HORIZONS-AMI trial. Coron Artery Dis 2017 0.75
354 Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials. JACC Cardiovasc Interv 2008 0.75
355 Contribution of early lumen loss after balloon angioplasty for in-stent restenosis to lumen loss at follow-up. Catheter Cardiovasc Interv 2004 0.75
356 Clinical applications of intravascular ultrasound in the implantation of drug-eluting stents. Expert Rev Cardiovasc Ther 2012 0.75
357 Accuracy of stent measurements using ECG-gated greyscale intravascular ultrasound images: a validation study. Ultrasound Med Biol 2009 0.75
358 Comparison of native coronary artery in-stent recurrence rates with longer versus shorter narrowings. Am J Cardiol 2002 0.75
359 Comparison of frequency of hemorrhagic stroke in patients <75 years versus > or =75 years of age among patients receiving glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions. Am J Cardiol 2004 0.75
360 Spontaneous coronary artery dissection with intra-adventitial hematoma detected by high-definition intravascular ultrasound. Coron Artery Dis 2016 0.75
361 Gamma radiation for in-stent restenosis: effect of lesion length on angiographic and clinical outcomes. Catheter Cardiovasc Interv 2004 0.75
362 Relationship between neointimal regrowth and mechanism of acute lumen gain during the treatment of in-stent restenosis with or without supplementary intravascular radiation. Catheter Cardiovasc Interv 2003 0.75
363 Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies. Coron Artery Dis 2014 0.75
364 Angiographic restenosis following intravascular beta-brachytherapy does not correlate with delivered dose: a study with dose volume histograms. Recurrence of in-stent restenosis after brachytherapy. Cardiovasc Radiat Med 2004 0.75
365 Serial intravascular ultrasound analysis of the impact of myocardial bridge on neointimal proliferation after coronary stenting in patients with acute myocardial infarction. J Interv Cardiol 2010 0.75
366 Comparison of stent length reported by the stent's manufacturer to that determined by quantitative coronary angiography at the time of implantation versus that determined by coronary computed tomographic angiography at a later time. Am J Cardiol 2013 0.75
367 Angiographic and volumetric intravascular ultrasound comparison between direct sirolimus-eluting stent implantation versus predilation. Am J Cardiol 2004 0.75
368 Hemodynamic and intravascular ultrasound assessment of an ambiguous left main coronary artery stenosis. Catheter Cardiovasc Interv 2007 0.75
369 In vivo validation of mathematically derived fractional flow reserve for assessing haemodynamics of coronary tandem lesions. EuroIntervention 2016 0.75
370 Reply: Clinical Significance of Intravascular Ultrasound-Detected Vascular Injury Following Chronic Total Occlusion Recanalization With Intraplaque Versus Subintimal Tracking Techniques. JACC Cardiovasc Interv 2017 0.75
371 Comparison of Plaque Burden and Vessel Remodeling in Obstructive Saphenous Vein Graft Lesions as Assessed by Intravascular Ultrasound and Dual-source Computed Tomography. J Thorac Imaging 2016 0.75
372 Safety and efficacy of manual stepping and overlapping of beta-emitter for diffuse in-stent restenosis lesions. Cardiovasc Radiat Med 2002 0.75
373 Intravascular ultrasound predictors of subacute vessel closure after balloon angioplasty or atherectomy. J Invasive Cardiol 2004 0.75
374 Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysis. J Invasive Cardiol 2007 0.75
375 Comparison of intravascular ultrasound to contrast-enhanced 64-slice computed tomography to assess the significance of angiographically ambiguous coronary narrowings. Am J Cardiol 2008 0.75
376 Multivessel spontaneous coronary artery dissection with angiographic documentation before and after the acute event. Coron Artery Dis 2015 0.75
377 Impact of different re-stenting strategies on expansion of a drug-eluting stent implanted to treat bare-metal stent restenosis. Am J Cardiol 2009 0.75
378 Intravascular ultrasound assessment of expansion of the sirolimus-eluting (cypher select) and paclitaxel-eluting (Taxus Express-2) stent in patients with diabetes mellitus. Am J Cardiol 2008 0.75
379 Effect of intravascular ultrasound findings on long-term repeat revascularization in patients undergoing drug-eluting stent implantation for severe unprotected left main bifurcation narrowing. Am J Cardiol 2011 0.75
380 Serial volumetric intravascular ultrasound assessment of native coronary artery versus saphenous vein grafts in-stent restenosis lesions after conventional catheter-based treatment. Am J Cardiol 2003 0.75
381 Does clinical presentation affect outcome among patients with acute coronary syndromes undergoing percutaneous coronary intervention? Insights from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study. Am Heart J 2012 0.75
382 Impact of remodeling on cardiac events in patients with angiographically mild left main coronary artery disease. J Invasive Cardiol 2007 0.75
383 Bypass to the left coronary artery system may accelerate left main coronary artery negative remodeling and calcification. Clin Res Cardiol 2013 0.75
384 Incidence and mechanism of late stent malapposition after phosphorus-32 radioactive stent implantation. Am J Cardiol 2003 0.75
385 Intravascular ultrasound analysis of the impact of gamma radiation therapy on the treatment of saphenous vein graft in-stent restenosis. Am J Cardiol 2002 0.75
386 Intravascular ultrasound analysis of plaque characteristics and postpercutaneous coronary intervention catheterization outcomes according to the remodeling pattern in narrowed saphenous vein grafts. Am J Cardiol 2012 0.75
387 The prediction of coronary artery disease based on non-invasive examinations and heme oxygenase 1 polymorphism versus virtual histology. J Invasive Cardiol 2013 0.75
388 Long-term changes in plaque burden and vessel remodeling in saphenous vein grafts: insights from serial intravascular ultrasound. Coron Artery Dis 2016 0.75
389 Randomized comparison of debulking followed by stenting versus stenting alone for ostial left anterior descending artery stenosis: intravascular ultrasound guidance. Am Heart J 2004 0.75
390 Applications of grayscale and radiofrequency intravascular ultrasound to image atherosclerotic plaque. J Nucl Cardiol 2010 0.75
391 Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton Bifurcation Stent in conjunction with an everolimus-eluting stent: IUVANT (Intravascular Ultrasound Evaluation of Tryton Stent) study. Catheter Cardiovasc Interv 2014 0.75
392 DICOM-based intravascular ultrasound signal intensity analysis: an Echoplaque Medical Imaging Bench study. Coron Artery Dis 2014 0.75
393 Serial intravascular ultrasound observations from the Tryton first-in-man study. EuroIntervention 2014 0.75
394 Usefulness of the angiographic pattern of in-stent restenosis in predicting the success of gamma vascular brachytherapy. Am J Cardiol 2003 0.75
395 Enhanced stent imaging improves the diagnosis of stent underexpansion and optimizes stent deployment. Catheter Cardiovasc Interv 2012 0.75